Your session is about to expire
← Back to Search
Piloting Mindfulness Meditation Program for Underserved Racial Minority Adults With Pulmonary Hypertension (MMPH Trial)
N/A
Waitlist Available
Led By Tania Von Visger
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at the end of the study intervention (week #8)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a mindfulness meditation program delivered via Zoom and a mobile app for adults in Western New York. The program aims to reduce stress and improve well-being through meditation, gentle movements, and restorative poses.
Eligible Conditions
- Pulmonary Hypertension
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and at the end of the study intervention (week #8)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at the end of the study intervention (week #8)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change From Baseline in Depressive Symptoms on the 27-point Patient Health Questionnaire-9 Scales (PHQ-9) to Week #8.
Secondary study objectives
Change From Baseline in Mindfulness Level on the 40-point Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) to Week #8.
Change From Baseline in PH-related Quality of Life on the 50-point EmPHasis-10 Scales to Week #8.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment ArmExperimental Treatment1 Intervention
This treatment Arm will receive MMPH intervention first, while the wait-listed group waits until this group is complete.
Then the wait-listed group will receive the same intervention after the first group completes it.
Group II: Comparison Arm or Waited List ArmActive Control1 Intervention
This active comparator Arm will not receive MMPH intervention at the beginning. They will receive the intervention once the Treatment Group completed the intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Meditation for Pulmonary Hypertension (MMPH)
2022
N/A
~20
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
268 Previous Clinical Trials
51,626 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
374 Previous Clinical Trials
409,267 Total Patients Enrolled
Tania Von VisgerPrincipal InvestigatorState University of New York at Buffalo School of Nursing